Browse studies

Find your next paid study

8 recruiting studies matching your filters

Omission of Immediate Postoperative Radiation in Patients With Intermediate Pathological Risk Features and Negative Two-Week Post-Operative ctHPVDNA (OPERATION Trial)

This single-arm Phase II trial evaluates whether omission of postoperative radiotherapy is feasible and oncologically safe in select patients with HPV-associat…

Squamous Cell CarcinomaHuman Papilloma Virus (HPV)Oropharyngeal Squamous Cell Carcinoma (OPSCC)

Estimated

~$10 – $6,250

Medical University of South CarolinaNCT07513389

A Global Multi-Center Prospective Observational Cohort to Support Drug Development in Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC)

Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials …

PSC

Estimated

~$10 – $1,125

PSC Partners Seeking a CureNCT06297993

Observational

Full Exchange Pharmacokinetic Model Analysis of Dynamic Contrast-Enhanced MRI Data for Identification of Vascular Habitats and Evaluation of Treatment Response in Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinomas

The purpose of this research study is to investigate the relationship between vascular habitats and treatment response AND to investigate the potential utility…

Oropharyngeal Squamous Cell Carcinoma (OPSCC)HPVHPV Positive Oropharyngeal Squamous Cell Carcinoma

Estimated

~$10 – $6,250

Abramson Cancer Center at Penn MedicineNCT07797738

Phase 2

Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

This study aims to determine the efficacy of 36 months once-daily fenofibrate in preventing clinically-detectable recurrence of primary sclerosing cholangitis …

Primary Sclerosing CholangitisLiver Transplant, ComplicationsPSC+1 more

Estimated

~$10 – $6,250

Mayo ClinicNCT06905054

PET/MRI Evaluation in Patients With Primary Sclerosing Cholangitis Using Intercellular Matrix Radiopharmaceuticals

This study aims to use positron emission tomography (PET)/magnetic resonance imaging (MRI) to diagnose and quantify PSC-related biliary tract fibrosis and to i…

PSC

Estimated

~$10 – $750

Massachusetts General HospitalNCT06252610

Phase 1

A Phase I Randomized Controlled Trial of Intratumoral Lidocaine Injection Before Transoral Robotic Surgery (TORS) and Neck Dissection for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Based on evidence that the local anesthetic lidocaine may have anticancer effects, this study will assess the safety and efficacy of intratumoral lidocaine inj…

Oropharyngeal Squamous Cell Carcinoma (OPSCCA)Oropharyngeal CancerHuman Papilloma Virus+1 more

Estimated

~$10 – $7,500

Ryan CareyNCT06747390

Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients

The purpose of this research is to create a collection of bile, bile duct brushings and medical information from people with Primary Sclerosing Cholangitis (PS…

Primary Sclerosing CholangitisPSCCholangiocarcinoma

Estimated

~$10 – $750

Mayo ClinicNCT04753996

Phase 2

A Phase 2 Randomized, Double Blind, Placebo Controlled, Parallel Study Evaluating the Safety and Efficacy of LB P8 in Patients With Primary Sclerosing Cholangitis (PSC)

The study is designed to assess the safety and efficacy of LB-P8 in patients with primary sclerosing cholangitis.

Primary Sclerosing Cholangitis (PSC)

Estimated

~$10 – $8,750

LISCure BiosciencesNCT06699121